Modeling Clostridioides difficile toxin pathogenesis and antiserum protection
Summary of: Wegner, Warschinke et al., 2026, Sci Rep
One of the biggest challenges in modeling infectious diseases in vitro isn’t the pathogen – it’s capturing the dynamic, multicellular environment in which host–pathogen interactions actually unfold.
In this new study from Jena University Hospital and the Paul-Ehrlich-Institute, the authors show that how we model Clostridioides difficile toxin exposure fundamentally shapes our ability to understand epithelial damage, immune activation, and therapeutic protection.
By directly comparing traditional 2D Transwells with a 3D immunocompetent Intestine‑on‑Chip, the team demonstrates that only a dynamically perfused, multicellular microenvironment can recapitulate the full complexity of toxin A (TcdA) and toxin B (TcdB) pathogenesis.
What this paper shows:
🧫 The Organ‑on-Chip model detects toxin‑induced damage at far lower concentrations than 2D inserts – highlighting greatly increased physiological sensitivity.
🛡️ Neutralizing antibodies against TcdA and TcdB effectively prevented epithelial disruption, cytokine release, and cytotoxicity, validating the chip as a preclinical testing platform for antibody‑based CDI therapies.
🧬 Integration of macrophages and circulating neutrophils (PMNs) amplified hallmark inflammatory responses, including IL‑6 and IL‑8 secretion, and enabled modeling of immune cell recruitment, adhesion, and tissue infiltration – phenomena impossible to capture in static cultures.
💥 Toxin‑specific damage patterns emerged clearly:
• TcdA → tight junction disruption & cell rounding
• TcdB → extensive epithelial destruction and necrotic cell loss
📊 Long‑term exposure revealed progressive, tissue‑layer‑specific injury, including vascular involvement and uncovered striking differences in recovery potential: TcdB‑treated tissues could regenerate, TcdA‑damaged tissues could not.
Together, this work underscores a critical lesson:
C. difficile pathogenesis is a multicellular, dynamic process and only physiologically relevant organ‑on‑chip microenvironments can fully reveal its complexity.
👏 Congratulations to Valentin D. Wegner, Maria Warschinke, Ibtissem Ben Brahim, Adrian Feile, Karen E. Huber, and Alexander S. Mosig on this impactful contribution to infection biology and therapeutic development!
Paper: Wegner, V.D., Warschinke, M., Brahim, I.B. et al. Modeling Clostridioides difficile toxin pathogenesis and antiserum protection in an immunocompetent intestine-on-chip platform. Sci Rep 16, 9233 (2026). https://doi.org/10.1038/s41598-026-44170-8
More interesting articles:
Blog, Disease-Modeling, Gut-on-Chip, Infection-Modeling
When butyrate drops, the gut loses more than a metabolite – it loses resilience
In this new study by Manuel Allwang, Maximilian Wipplinger, and Parastoo Akbarimoghaddam and colleagues, published in Small, the authors show why that loss may be especially important when inflamed tissue is challenged by the opportunistic fungus Candida albicans.
Read MoreBlog, Drug Development, Liver-on-Chip
Evaluation of a liver-chip model for clearance prediction
In this new publication led by scientists at Novartis and the University of Tübingen, the authors take a deep, engineering level look at the performance of a microphysiological liver on chip model for predicting human hepatic clearance, a central parameter in preclinical drug development.
Read MoreBlog, Gut-on-Chip, Infection-Modeling
Modeling Clostridioides difficile toxin pathogenesis and antiserum protection
In this new study from Jena University Hospital and the Paul-Ehrlich-Institute, the authors show that how we model Clostridioides difficile toxin exposure fundamentally shapes our ability to understand epithelial damage, immune activation, and therapeutic protection.
Read More